Biomerica, Inc. (BMRA)

Biomerica Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	9.72	5.92	4.2	8.64	0.69
Cash & Cash Equivalents	9.72	5.92	4.2	8.64	0.69
Cash Growth	64.26%	40.90%	-51.40%	1158.19%	-43.00%
Receivables	0.72	0.77	1.46	1.77	1.45
Inventory	2.06	2.42	3.21	2.85	2.15
Other Current Assets	0.3	0.32	0.37	1.51	0.2
Total Current Assets	12.8	9.43	9.23	14.77	4.49
Property, Plant & Equipment	1.25	1.52	1.86	1.99	0.35
Long-Term Investments	0.17	0.17	0.17	0.17	0.17
Goodwill and Intangibles	0.17	0.17	0.29	0.17	0.11
Other Long-Term Assets	0.08	0.1	0.26	0.17	0.13
Total Long-Term Assets	1.66	1.95	2.59	2.49	0.75
Total Assets	14.45	11.37	11.82	17.26	5.25
Accounts Payable	0.89	0.97	0.58	0.99	1.04
Current Debt	0.3	0.34	0	0	0
Other Current Liabilities	0.76	0.7	0.72	0.49	0.23
Total Current Liabilities	1.95	2.01	1.3	1.48	1.26
Long-Term Debt	0.79	1.04	1.29	1.57	0
Total Long-Term Liabilities	0.79	1.04	1.29	1.57	0
Total Liabilities	2.73	3.05	2.59	3.05	1.26
Total Debt	1.08	1.38	1.29	1.57	0
Debt Growth	-21.54%	6.77%	-17.72%	-	-
Retained Earnings	-42.22	-35.08	-30.55	-23.1	-19.59
Comprehensive Income	-0.11	-0.07	-0.05	-0.04	-0.04
Shareholders' Equity	11.72	8.33	9.23	14.21	3.98
Net Cash / Debt	8.64	4.54	2.91	7.07	0.69
Net Cash / Debt Growth	90.33%	56.07%	-58.88%	929.63%	-43.00%
Net Cash Per Share	0.61	0.36	0.24	0.70	0.07
Working Capital	10.85	7.42	7.93	13.29	3.23
Book Value Per Share	0.83	0.66	0.77	1.40	0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).